CINECA IRIS Institutional Research Information System

DI PAOLO, ANTONELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.128
AS - Asia 7.847
EU - Europa 5.950
SA - Sud America 1.261
AF - Africa 376
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 3
Totale 33.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.623
SG - Singapore 2.412
CN - Cina 2.110
IT - Italia 2.034
HK - Hong Kong 1.222
BR - Brasile 1.047
SE - Svezia 925
VN - Vietnam 630
DE - Germania 532
BG - Bulgaria 483
FR - Francia 398
GB - Regno Unito 390
CA - Canada 350
TR - Turchia 313
FI - Finlandia 275
RU - Federazione Russa 236
IN - India 218
JP - Giappone 193
UA - Ucraina 161
KR - Corea 155
CI - Costa d'Avorio 101
BD - Bangladesh 98
CH - Svizzera 78
NL - Olanda 76
BE - Belgio 73
MX - Messico 73
IQ - Iraq 70
ZA - Sudafrica 64
AR - Argentina 63
SA - Arabia Saudita 53
PL - Polonia 52
UZ - Uzbekistan 51
ES - Italia 47
PK - Pakistan 46
ID - Indonesia 43
GR - Grecia 41
NG - Nigeria 39
CO - Colombia 34
EG - Egitto 34
AT - Austria 31
EC - Ecuador 29
AU - Australia 27
MA - Marocco 27
IE - Irlanda 25
IR - Iran 23
SN - Senegal 23
AE - Emirati Arabi Uniti 22
PH - Filippine 22
PY - Paraguay 20
VE - Venezuela 20
DK - Danimarca 19
KE - Kenya 19
MY - Malesia 19
CL - Cile 18
JO - Giordania 18
TT - Trinidad e Tobago 18
TN - Tunisia 17
DZ - Algeria 16
TH - Thailandia 15
OM - Oman 13
CZ - Repubblica Ceca 12
LT - Lituania 12
TW - Taiwan 12
CR - Costa Rica 11
NP - Nepal 11
PE - Perù 11
BO - Bolivia 10
KZ - Kazakistan 9
LB - Libano 8
NI - Nicaragua 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
IL - Israele 7
JM - Giamaica 7
PS - Palestinian Territory 7
RS - Serbia 7
UY - Uruguay 7
BB - Barbados 6
HU - Ungheria 6
KW - Kuwait 6
RO - Romania 6
BY - Bielorussia 5
ET - Etiopia 5
KG - Kirghizistan 5
NO - Norvegia 5
PA - Panama 5
AM - Armenia 4
BF - Burkina Faso 4
BJ - Benin 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
BH - Bahrain 3
CG - Congo 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
KH - Cambogia 3
LK - Sri Lanka 3
MD - Moldavia 3
PT - Portogallo 3
Totale 33.533
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.783
Ashburn 1.756
Houston 1.613
Ann Arbor 1.492
Fairfield 1.433
Singapore 1.375
Hong Kong 1.201
Santa Clara 834
Dallas 821
Chandler 788
San Jose 749
Seattle 627
Wilmington 504
Cambridge 492
Shanghai 490
Sofia 479
Milan 439
Beijing 429
New York 348
Serra 294
Boardman 258
Ottawa 256
Los Angeles 232
Princeton 231
Lawrence 192
Hefei 179
Lauterbourg 178
Medford 174
Jacksonville 173
Izmir 159
Tokyo 159
Nanjing 137
Ho Chi Minh City 136
Seoul 135
Council Bluffs 133
Dearborn 130
Hanoi 121
Des Moines 118
Munich 107
Dong Ket 103
Abidjan 101
London 98
Istanbul 93
Florence 91
Pisa 89
Helsinki 83
San Diego 83
Washington 83
Redondo Beach 80
Buffalo 78
Frankfurt am Main 78
The Dalles 72
São Paulo 70
Rome 69
Brussels 67
Columbus 67
Redwood City 60
Boulder 58
Nanchang 58
Chicago 57
Kunming 49
Bern 48
Ogden 45
Rio de Janeiro 42
Tashkent 42
Turku 42
Lagos 38
Falls Church 37
Belo Horizonte 36
Shenyang 35
Norwalk 34
Pune 34
Changsha 33
Warsaw 33
Bremen 32
Hebei 29
Phoenix 27
Toronto 27
Zurich 27
Baghdad 24
Jiaxing 24
Lucca 24
Orem 24
Dakar 23
Ankara 22
Dhaka 22
Düsseldorf 21
Guangzhou 21
Montreal 21
San Francisco 21
Curitiba 20
Johannesburg 20
Jüchen 20
Riyadh 20
Cape Town 19
Jakarta 19
Nuremberg 19
Stockholm 19
Vienna 19
Da Nang 18
Totale 23.923
Salva come PNG Salva come JPEG
Nome #
DECONTAMINAZIONE CON GENTAMICINA ORALE NEI PAZIENTI CON COLONIZZAZIONE INTESTINALE DA KLEBSIELLA PNEUMONIAE PRODUTTRICE DI KPC IN CORSO DI EPIDEMIA 536
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity 354
Procedimento attuato per mezzo di un elaboratore per la determinazione dei tempi di ritenzione e dei valori di concentrazione di analiti in una miscela 284
Determination of mitotane and principal metabolite by a simple HPLC-UV method and its validation in human plasma sample 279
A rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasma 273
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference LC-MS/MS 267
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers 251
Gender, MGMT methylation, and levetiracetam plasma levels correlate with survival benefit in glioblastoma patients treated with adjuvant temozolomide: results from a non-interventional retrospective clinical study 251
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. 244
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review—Part I 243
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 243
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study 242
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. 235
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia 234
IN THE CHRONIC MYELOID LEUKEMIA THE SALIVARY PROTEOMICS RECAPITULATES SOME ASPECTS OF THE LEUKEMIC STEM CELL. LA CELLULA STAMINALE LEUCEMICA E LA PROTEOMICA SALIVARE: IL MODELLO DELLA LEUCEMIA MIELOIDE CRONICA 230
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients 224
Determination of mitotane and metabolite by a simple HPLC-UV method and application in plasma samples 220
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference Mass Spectrometry 218
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 217
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 215
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 214
Autoimmune diseases and myeloid hematological disorders: a possible pathogenetic relationship 211
Pharmacogenetics in Oncology 210
Personalized medicine of monoclonal antibodies in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and beyond 210
The role of thymidylate synthase as a molecular biomarker 209
5-Fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer 208
Fungicidal activity and PK/PD of caspofungin as tools to guide antifungal therapy in a fluconazole-resistant C. parapsilosis candidemia 208
Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicity 204
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. 202
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 202
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib 202
Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily 199
Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment. 199
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer 198
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients 198
Linezolid in the central nervous system: Comparison between cerebrospinal fluid and plasma pharmacokinetics 196
Impact of locoregional approaches to liver metastases in patients with colorectal cancer 195
5-Fluorouracil exposure in adjuvant chemotherapy regimens is significantly related to disease free survival in colorectal cancer patients 195
A case report of a TDM-guided optimization of mitotane for a safe and effective long-term treatment 194
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 194
Chronic administration of suramin induces neurotoxicity in rats 192
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients 192
Methods: For studying pharmacogenetic profiles of combination chemotherapeutic drugs 192
Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges 192
Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update 191
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 188
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 188
Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction 187
Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin 187
Appropriateness of repetitive therapeutic drug monitoring and laboratory turn around time 187
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 186
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer 185
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers 185
ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview 185
A new HPLC-UV method compared with HPLC-MS for daptomycin levels in human plasma samples 185
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells 184
Serotonin syndrome and the T102-->C polymorphism of the 5-HT2A receptor: a case report 184
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. 184
Therapeutic monitoring of Piperacillin in ICU patients 184
Daptomycin concentrations in valve tissue and vegetation in patients with bacterial endocarditis 183
Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World 183
Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis 183
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role 182
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. 181
The pharmacological bases of the antiangiogenic activity of paclitaxel 181
Pharmacokinetic and pharmacogenetic predictive markers of irinotecan activity and toxicity 181
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma 180
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 180
Different recommendations for daptomycin dosing over time in patients with severe infections 179
Genotype A1/A2 associated with neuroleptic malignant syndrome 179
Time-dependent Pharmacokinetics of 5-fluorouracil and association with treatment tolerability in the adjuvant setting of colorectal cancer 178
Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction 178
Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate 178
Precision medicine in lymphoma by innovative instrumental platforms 178
Predicting survival with artificial neural networks 177
Clinical Pharmacokinetics of Antibacterials in Cerebrospinal Fluid 177
Irinotecan in 5-fluorouracil-refractory colorectal cancer 175
Prediction of fluoropyrimidine toxicities by screening DPYD genetic variants. 171
Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer 170
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: A preclinical study 170
Liposomal anticancer therapy: pharmacokinetic and clinical aspects 169
Linezolid for endocarditis: a case series of 14 patients 169
Pharmacogenetic determinants of anti-cancer drug activity and toxicity 168
Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: the relevance of concomitant systemic antibiotic therapy. 167
Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell lines 166
Administration interval and daptomycin toxicity: a case report of rhabdomyolysis 165
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. 165
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib 163
Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo. 163
Improved analysis of 5-Fluorouracil and 5,6-dihydro-5-Fluorouracil by HPLC with diode array detection for determination of cellular dihydropyrimidine dehydrogenase activity and pharmacokinetic profiling 162
Combined FAMD and ANOVA investigation leads to significant association between the hOCT1/ABCB1 diplotype and both efficacy and tolerability in patients affected by chronic myeloid leukemia 162
Pharmacogenetics of Antiangiogenic Therapy 161
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia 161
Cardiovascular implantable electronic device endocarditis treated with daptomycin with or without transvenous removal 160
Pharmacogenetics of BCR/ABL inhibitors in chronic myeloid leukemia 159
Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections 158
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers 158
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer 156
Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patients 156
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo 156
Totale 19.854
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021308 0 0 0 0 0 0 0 0 0 0 0 308
2021/20222.361 69 134 90 128 378 385 86 125 93 95 131 647
2022/20232.747 390 318 181 232 301 410 39 210 453 22 168 23
2023/20242.101 229 237 253 123 269 371 95 104 51 50 87 232
2024/20257.093 41 243 78 344 700 694 595 403 662 842 720 1.771
2025/20267.287 465 931 887 722 740 667 1.059 388 481 610 235 102
Totale 34.131